Intel CEO Buys the Dip as the Street Cuts and Covers

Intel has shed 35% in a week and nearly half its value over the past month, yet the CEO just spent almost $10 million buying stock in the open market at $64.73.

That purchase by Lip-Bu Tan on November 2, filing the day it occurred, is the most concrete piece of information in this week's data. It was not made under a 10b5-1 pre-arranged plan. At 150,000 shares at $64.73 apiece, it represents his second material open-market buy in three months: he paid $95 per share for 105,263 shares in August. The 90-day net across all insiders is a positive 255,263 shares, worth roughly $19.7 million. Insider selling over the same period has been confined to tax-withholding transactions tied to option exercises at the foundry level, compensation mechanics rather than conviction sales. Against a backdrop where every professional analyst who published a note last week was cutting targets, the CEO buying in size without a plan in place is an outlier that belongs at the top of this note.

Short sellers, who built steadily through September to a cycle peak of 169 million borrowed shares before Q3 results, have not moved aggressively in either direction since the Q4 collapse. Borrowed shares now stand at 153 million, or 3.2% of free float, up 1.9% on the week but still well below the peak. The borrow market offers no friction at all: availability is effectively uncapped, and the cost to borrow is running at 0.29%, down 14% on the week and among the lowest readings of the past six weeks. There is no evidence in the lending market of a rush to build fresh short exposure following the earnings disaster. Options traders have moved more cautiously. The put/call ratio closed at 0.91, nearly two standard deviations above its 20-day mean of 0.87, with the past two sessions showing the most elevated defensive positioning since the Q4 print. The PCR peaked at 0.932 on November 2 before easing slightly, still well above where it sat for most of October. The 52-week high on the ratio is 1.16, so there is room for it to push further, but the current level reflects genuine caution rather than outright panic.

The Street sits in an uncomfortable position: 35 Hold ratings against just 2 Outperform calls, with a consensus mean price target around $93.88 after the wave of cuts that followed the October 29 print. That is still more than 50% above where the stock closed Tuesday. The gap is wide enough to be almost meaningless as a near-term anchor. The bull case rests on data center and AI server demand, where revenue grew nearly 80% year over year, and on the foundry turnaround: Intel 3 and 18A costs are reported to have fallen 15% and 40% from first-quarter levels, with 18A yields reaching industry-standard levels. The bear case is harder to dismiss. PC unit volumes are expected to fall around 12% in 2026 and another 10% in 2027. Gross margin guidance for Q4 came in at 38%. Capital expenditure of $20 billion this year is running ahead of any near-term free cash flow. JP Morgan's Harlan Sur held Neutral and cut to $80 from $85 on October 30. UBS lowered to $80 from $100. Neither move represents a change in directional view. The price-to-book has compressed to 2.45, down from above 4 a month ago, and the PE on trailing earnings has collapsed to 34.6 as earnings estimates have fallen. EPS momentum ranks in the 10th percentile over 30 days and the 15th over 90 days.

Retail attention tells a different story from professional caution. Wikipedia page views and ORTEX stock page traffic have surged to 4.79 standard deviations above Intel's own 90-day average as of October 31, the highest reading in the alt-data record and a sign of how far the Q4 collapse has pushed the name into public consciousness. Retail engagement at this level following a large price drop is a known feature of large-cap collapses, and it does not carry a measured relationship to the company's reported financials. It describes who is looking, not what they will find.

Closest peer AMD fell 13.6% on the week, a sharp drop in its own right but roughly half Intel's loss. TER dropped 16.8%. The sector backdrop is clearly negative, but Intel's magnitude of underperformance is specific to the Q4 print rather than a sector-wide rotation. The next earnings event is scheduled for January 21, 2027, leaving 78 days for the foundry cost narrative and PC inventory data to either reinforce or undercut the positions being taken now.

What to watch: whether the CEO's open-market purchase is followed by buying from other directors or officers, and whether short interest begins to rebuild from its current level as the stock stabilises above $60.